BioSpace News Archive

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that it will participate in Citi’s 16th Annual BioPharma Virtual Conference 2021 investor conference.

TriSalus Life Sciences®, an emerging immuno-oncology company committed to transforming outcomes for patients with liver and pancreatic tumors, today announced its first patient enrolled in the Pressure Enabled Regional Immuno-Oncology (PERIO)-01 clinical study evaluating the administration of SD-101, an investigational toll-like receptor 9 (TLR9) agonist, in adults with metastatic uveal melanoma.

CEVEC Pharmaceuticals GmbH announced the signing of an agreement with UCB S.A. on the evaluation and use of CEVEC’s proprietary ELEVECTA Technology for the research, development, and manufacturing of Adeno-Associated Virus vectors for gene therapy applications.

Illumina, Inc. (NASDAQ: ILMN) and Merck (known as MSD outside the United States and Canada) today announced a partnership to develop and commercialize tests that identify genetic mutations used in the assessment of homologous recombination deficiency (HRD)

HOOKIPA Pharma Inc. today announced that HOOKIPA’s management team will participate and present at the following upcoming virtual investor conferences: Morgan Stanley 19th Annual Global Healthcare Conference, September 9 – 10 and 13 – 15, 2021

Paragon 28® is pleased to announce the launch of its Silverback™ Span Plating System, which was specifically designed to be used in combination with a structural allograft or a titanium cage in cases where a significant void is present at the talus and/or ankle joint.

Currently there are more than 40 types of HPV strains capable of affecting the genital areas, mouth and throat of both males and females.

Michael J. Willner has practiced as both an Attorney and a Certified Public Accountant.

Medtronic plc, the global leader in medical technology, announced it will participate virtually in the following upcoming investor conferences

PolarityTE to Attend H.C. Wainwright 23rd Annual Global Investment Conference and 2021 Cantor Virtual Global Healthcare Conference